Abstract
Calcium pectinate (CaP)—the insoluble salt of pectin—can potentially be used as a colon-specific drug delivery system. The use of CaP as a carrier was based on the assumption that, like pectin, it can be decomposed by specific pectinolytic enzymes in the colon but that it retains its integrity in the physiological environment of the small bowel. The biodegradation of the carrier was characterized by monitoring the percent cumulative release of the insoluble drug indomethacin, incorporated into pectin or CaP matrices. Compressed tablets of pectin and indomethacin were analyzed for degradation in the presence of Pectinex 3XL, a typical pectinolytic enzyme mixture, and in the presence of the human colonic bacterium Bacteroides ovatus. The degradation of CaP-indomethacin tablets was assessed in the presence of Pectinex 3XL and in rat cecal contents. The release of indomethacin was significantly increased (end-time percentage cumulative release vs control) in the presence of Pectinex 3XL (89 ± 20 vs 16 ± 2 for CaP tablets), Bacteroides ovatus (12 and 22 vs 5.2 for pectin tablets), and rat cecal contents (61 ± 16 vs 4.9 ± 1.1 for CaP tablets). The weight loss of tablet mass was significantly higher (end-time dry weight vs control) in the presence of Pectinex 3XL (0 vs 75 ± 6% of initial weight for CaP tablets). These findings indicate the potential of CaP, compressed into tablets with insoluble drug, to serve as a specific drug delivery system to the colon.
Similar content being viewed by others
REFERENCES
C.-M. Lehr, F. G. P. Poelma, H. E. Junginger, and J. J. Tukker. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:235–240 (1991).
J. N. Hunt and M. T. Knox. A relation between the chain length of fatty acids and the slowing of gastric emptying. J. Physiol. (London) 194:327–336 (1968).
J. H. Meyer, J. B. Dressman, A. Fink, and G. L. Amidon. Effect of size and density on canine gastric emptying of non digestible solids. Gastroenterology 89:805–813 (1985).
S. S. Davis, J. G. Hardy, and J. W. Fara. Transit of pharmaceutical dosage forms through the small intestine. Gut 27:886–892 (1986).
D. S. Levine, V. A. Raisys, and V. Ainardi. Coating of oral beclomethasone dipropionate capsules with cellulose acetate phthalate enhances delivery of topically active anti-inflammatory drug to the terminal ileum. Gastroenterology 92:1037–1044 (1987).
S. N. Rasmussen, S. Rondesen, E. F. Hvidberg, S. Honore Hansen, V. Binder, S. Halskov, and H. Flachs. 5-Aminosalicylic acid in a slow-release preparation: Bioavailability, plasma level, and excretion in humans. Gastroenterology 83:1062–1070 (1982).
A. Rubinstein. Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos. 11:465–475 (1990).
U. Klotz. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin. Pharmacokin. 10:285–302 (1985).
D. R. Friend and G. W. Chang. Drug glycosides: Potential prodrugs for colon-specific drug delivery. J. Med. Chem. 28:51–57 (1985).
T. N. Tozer, J. Rigod, A. D. McLeod, R. Gungon, M. K. Hoag, and D. R. Friend. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig. Pharm. Res. 8:445–454 (1991).
C. Larsen, E. Harboe, M. Johansen, and H. P. Olsen. Macromolecular prodrugs. XVI. Colon-targeted delivery—comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastro-intestinal tract. Pharm. Res. 6:995–999 (1989).
C. Larsen and B. H. Jensen. Stability of ketoprofen-dextran ester prodrugs in homogenates of various segments of the pig GI tract. Acta Pharm. Nord. 3:41–44 (1991).
P. Kopeckova and J. Kopecek. Release of 5-aminosalicylic acid from bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers by azoreductases in vitro. Makromol. Chem. 191:2037–2045 (1990).
M. Saffran, G. S. Kumar, C. Savariar, J. C. Burnham, F. Williams, and D. C. Neckers. A new approach to the oral administration of insulin and other peptide drugs. Science 233:1081–1084 (1986).
A. Rubinstein, D. Nakar, and A. Sintov. Colonic drug delivery: Enhanced release of indomethacin from cross-linked chondroitin matrix in rat cecal content. Pharm. Res. 9:276–278 (1992).
G. A. Towle and O. Christensen. Pectin. In R. L. Whistler and J. N. BeMiller (eds.), Industrial Gums, Polysaccharidesm and Their Derivatives, Academic Press, New York, 1973, pp. 429–461.
A. A. Salyers, J. R. Vercellotti, S. E. H. West, and T. D. Wilkins. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 33:319–322 (1977).
S. C. Werch and A. C. Ivy. On the fate of ingested pectin. Am. J. Digest. Dis. 8:101–105 (1941).
J. F. Thibault and M. Rinaudo. Interactions of mono-and divalent counterions with alkali-and enzyme-deesterified pectins in salt-free solutions. Biopolymers 24:2131–2143 (1985).
R. P. Graham and A. D. Shepherd. Pilot plant production of low-methoxyl pectin from citrus peel. Agr. Food Chem. 1:993–1001 (1953).
T. Bitter and H. M. Muir. A modified uronic acid carbazole reaction. Anal. Biochem. 4:330–334 (1962).
D. A. Powell, E. R. Morris, M. J. Gidley, and D. A. Rees. Conformation and interactions of pectins. II. Influence of residue sequence on chain association in calcium pectate gels. J. Mol. Biol. 155:517–531 (1982).
I. Lutsky, F. Aizer, and N. Mor. The Sabra rat: Definition of a laboratory animal. Isr. J. Med. Sci. 20:603–612 (1984).
L. Hankin and D. Sands. In M. L. Speck (ed.), Compendium of Methods for Microbiological Examination of Foods, APHA Intersociety/Agency Committee on Microbiological Methods for Foods, 1976, pp. 208–214.
A. A. Salyers and J. A. Z. Leedle. Carbohydrate metabolism in the human colon. In D. J. Hentges (ed.), Human Intestinal Microflora in Health and Disease, Academic Press, New York, 1983, pp. 129–146.
J. Heller. Use of polymers in controlled release of active agents. In J. R. Robinson and V. H. Lee (eds.), Controlled Drug Delivery Fundamentals and Applications, Marcel Dekker, New York, 1987, pp. 179–212.
E. R. Morris, D. A. Powell, M. J. Gidley, and D. A. Rees. Coformation and interactions of pectins. I. Polymorphism between gel and solid states of calcium polygalacturonate. J. Mol. Biol. 155:507–516 (1982).
G. Hawksworth, B. S. Drasar, and M. J. Hill. Intestinal bacteria and the hydrolysis of glycosidic bonds. J. Med. Microbiol. 4:451–459 (1971).
S. Passaretti, M. Sorghi, E. Colombo, G. Mazzotti, A. Tittobello, and M. Guslandi. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome. Int. J. Clin. Phamracol. Ther. Tox. 27:47–50 (1989).
P. Kopeckova, M. A. Longer, J. F. Woodley, R. Duncan, and J. Kopecek. Release of p-nitroaniline from oligopeptide side chains attached to N-(2-hydroxypropyl)methacrylamide copolymers during incubation with rat intestinal brush border enzymes. Makromol. Chem. Rapid Commun. 12:101–106 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubinstein, A., Radai, R., Ezra, M. et al. In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier. Pharm Res 10, 258–263 (1993). https://doi.org/10.1023/A:1018995029167
Issue Date:
DOI: https://doi.org/10.1023/A:1018995029167